NEW YORK (GenomeWeb) – Laboratory Corporation of America reported today that its second quarter revenues increased around 3 percent year over year as the firm beat Wall Street estimates on the top and bottom line.

The Burlington, NC-based clinical lab giant reported revenues of $1.52 billion for the three months ended June 30, up from $1.47 billion for Q2 2013. Analysts, on average, had estimated revenues of $1.50 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.